Tower Research Capital (TRC)’s Silo Pharma SILO Stock Holding History

Tower Research Capital (TRC)’s Portfolio SILO Stock Details SILO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$603	Sell	112 -1	-0.9%	-$5	﹤0.01%	4830
2025 Q4	$576	Sell	113 -1	-0.9%	-$7	﹤0.01%	4868
2025 Q3	$1.18K	Sell	114 -2	-2%	-$20	﹤0.01%	4857
2025 Q2	$1.09K	Buy	116 +19	+20%	+$218	﹤0.01%	4878
2025 Q1	$1.7K	Sell	97 -206	-68%	-$4.61K	﹤0.01%	4665
2024 Q4	$4.05K	Buy	303 +32	+12%	+$495	﹤0.01%	4531
2024 Q3	$4.47K	Sell	271 -173	-39%	-$3.69K	﹤0.01%	4535
2024 Q2	$6.66K	Buy	444 +149	+51%	+$3.81K	﹤0.01%	4554
2024 Q1	$8.64K	Sell	295 -172	-37%	-$4.09K	﹤0.01%	3987
2023 Q4	$10.1K	Buy	467 +141	+43%	+$3.2K	﹤0.01%	4294
2023 Q3	$8.17K	Buy	326 +4	+1%	+$119	﹤0.01%	4384
2023 Q2	$9.91K	Sell	322 -44	-12%	-$1.43K	﹤0.01%	4198
2023 Q1	$12K	Buy	366 +288	+369%	+$10.5K	﹤0.01%	4120
2022 Q4	$4K	Buy	+78	New	+$4.56K	﹤0.01%	5062

Other funds holding SILO

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tower Research Capital (TRC)'s SILO Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Silo Pharma (SILO) stake by 0.88% in Q1 2026, selling an estimated $5 and leaving 112 shares worth $603. The position accounts for ﹤0.01% of the portfolio, ranked #4830.

Tower Research Capital (TRC) first reported a position in SILO in Q4 2022 and has held it in 14 quarters since. The position peaked at $12K in Q1 2023. 14 funds tracked by Wall St. Rank hold SILO as of Q1 2026.

Tower Research Capital (TRC) held 112 shares of Silo Pharma worth $603 as of Q1 2026.
Tower Research Capital (TRC) sold 1 Silo Pharma share in Q1 2026, an estimated $5.
Silo Pharma made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4830 holding.
Tower Research Capital (TRC) first reported a position in Silo Pharma in Q4 2022 and has held it in 14 quarters since.
Tower Research Capital (TRC)'s Silo Pharma position peaked at $12K in Q1 2023.
14 funds tracked by Wall St. Rank held Silo Pharma as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.